• Contact
Augurex
  • Solutions
    • Solution Portfolio
    • Rheumatoid Arthritis
    • Axial Spondyloarthritis
    • Find a Test
  • Science
  • About
    • Company
    • Leadership
  • News
  • Careers
Select Page
USPTO Awards Another Patent; New Data Demonstrating 14-3-3η as a Biomarker for Monitoring Therapy Response

USPTO Awards Another Patent; New Data Demonstrating 14-3-3η as a Biomarker for Monitoring Therapy Response

by Simran Chahal | Jan 1, 2019 | Business, Health, News

USPTO Awards Patent for Citrullinated 14-3-3: Expanding Augurex’s Portfolio in the Diagnosis of Rheumatoid Arthritis (RA) On November 20th, 2018 the US Patent and Trademark Office (USPTO) awarded patent number 10,132,806 entitled “Antigens Derived From...
Page 3 of 3«123
©2024 Augurex Life Sciences. All Rights Reserved. Website by Vanooms Media Inc.